Dr. Fast joined the University of Manitoba in 2012. He leads a team that is responsible for assessing and moving research-based technologies into the private sector as well as facilitating collaborative research partnerships with industry partners. He is also the past Chair of the Canadian Committee of AUTM. Previously, Darren was the Senior Intellectual Property Advisor at the Public Health Agency of Canada. He was also the President of Solalta Advisors, providing market and business development services for early-stage, technology-based companies. Prior to Solalta, Darren was Chief Technology Officer for the Western Life Sciences Venture Fund, where he created new companies based on licensed technologies. Darren has also served as manager, Product Planning and Development at Viventia Biotech, where he was responsible for the development of several human therapeutic antibody projects. He has a Ph.D. in biochemistry from the University of Alberta and an M.Sc. in chemistry from the University of Manitoba.